Tacholiquin® or its active ingredient tyloxapol has been successfully administered via inhalation for more than 50 years. Tyloxapol is a surface-active wetting agent or surfactant and has a mucolytic effect.
Its purely physical effect results from three important components:
- Secretolysis: Viscous mucus is liquefied and can be more easily coughed up
- Roll-up effect: Mucus is detached at its base, rolls up and can be transported away by the cilia of the respiratory tract.
- Lower surface tension reduces the viscosity of the mucus.
Diseases with excessive mucus production in the airways inhibit the self-cleaning function which is normally ensured by ciliary activity. Tacholiquin® helps to restore normal activity of these cilia.
Tacholiquin® is indicated against many diseases of the respiratory tract or the lung which are particularly characterised by very viscous mucus (sputum):
- Acute and chronic irritation of the respiratory tract
- Pseudo-croup (viral laryngitis in conjunction with coughing and shortness of breath)
- Bronchial asthma
- Bronchiectasis (abnormal widening of the bronchi)
- Abscesses (accumulation of pus in a tissue cavity)
- Atelectases (non-ventilated parts of the lung due to partial collapse of the lung)
Tacholiquin® can also be used whenever the respiratory tract’s self-cleaning function is impaired:
- Impaired breathing following surgery
- Myasthenia (nervous system disorder involving muscle weakness)
- Impaired consciousness
- Apnoea in new-borns and inability to swallow
- Following radiation
Premature babies, infants, small children as well as adults benefit from this very well-tolerated preparation with its purely physical mode of action which does not affect the physiological conditions at the mucosa.
Tacholiquin® is suitable for inhalation and instillation. Commercially available nebulisers (such as PARIboy) can be used for inhalation. Do not use hot-water boilers.